Cargando…
Mutational spectrum of adult T-ALL
Novel target discovery is warranted to improve treatment in adult T-cell acute lymphoblastic leukemia (T-ALL) patients. We provide a comprehensive study on mutations to enhance the understanding of therapeutic targets and studied 81 adult T-ALL patients. NOTCH1 exhibitedthe highest mutation rate (53...
Autores principales: | Neumann, Martin, Vosberg, Sebastian, Schlee, Cornelia, Heesch, Sandra, Schwartz, Stefan, Gökbuget, Nicola, Hoelzer, Dieter, Graf, Alexander, Krebs, Stefan, Bartram, Isabelle, Blum, Helmut, Brüggemann, Monika, Hecht, Jochen, Bohlander, Stefan K., Greif, Philipp A., Baldus, Claudia D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413615/ https://www.ncbi.nlm.nih.gov/pubmed/25595890 |
Ejemplares similares
-
FAT1 expression and mutations in adult acute lymphoblastic leukemia
por: Neumann, M, et al.
Publicado: (2014) -
Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients
por: Bartram, Isabelle, et al.
Publicado: (2014) -
FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors
por: Neumann, Martin, et al.
Publicado: (2013) -
Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL
por: Bartram, Isabelle, et al.
Publicado: (2015) -
Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations
por: Neumann, M, et al.
Publicado: (2012)